Nurix Therapeutics Inc. (NRIX)
NASDAQ · Healthcare
Nurix Therapeutics Inc. Income Statement 2019–2025
| Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenue | 84.0M | 54.5M | 77.0M | 38.6M | 29.8M | 17.8M | 31.1M |
| Gross Profit | — | — | — | — | — | — | — |
| Profitability | |||||||
| Operating Income | -285.7M | -213.0M | -155.1M | -183.9M | -117.9M | -65.0M | -22.2M |
| EBITDA | -276.9M | -203.7M | -147.5M | -178.5M | -115.1M | -62.8M | -19.9M |
| Net Income | -264.5M | -193.6M | -143.9M | -180.4M | -117.2M | -43.2M | -21.7M |
| Per Share Data | |||||||
| EPS (diluted) | $-3.05 | $-2.88 | $-2.65 | $-3.71 | $-2.73 | — | — |
| Shares Outstanding (dil.) | 87M | 67M | 54M | 49M | 43M | 39M | 4M |
Nurix Therapeutics Inc. Income Statement — FAQ
Nurix Therapeutics Inc. (NRIX) income statement over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NRIX's income statement history?
The chart and table above show Nurix Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.